1 / 13

Hepatitis C screening

Hepatitis C screening. Curtis Barry, MD ECHO. The Hepatitis C Epidemic. Prevalence of hepatitis C Worldwide: 170 million (3%) US: 4 million (1.8%) HCV Ab positive 80% are estimated to be viremic Most patients are asymptomatic until irreversible damage occurs.

polkr
Download Presentation

Hepatitis C screening

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hepatitis C screening Curtis Barry, MD ECHO

  2. The Hepatitis C Epidemic • Prevalence of hepatitis C • Worldwide: 170 million (3%) • US: 4 million (1.8%) HCV Ab positive • 80% are estimated to be viremic • Most patients are asymptomatic until irreversible damage occurs CDC. MMWR 1998:47 (No. RR-19);1-39

  3. The Hepatitis C Epidemic (cont.) CDC. MMWR. 1998; 47(No. RR-19):1-39. NIH Consensus Development Conference Panel Statement Management of Hepatitis C, 2002 • A leading cause of cirrhosis in the US • 10,000-20,000 deaths/year • This number expected to triple in the next 10 years (without therapy) • Associated with an increased risk of liver cancer • Accounts for an estimated 1/3 of HCC cases in the US • Leading indication for liver transplantation in US

  4. Clinical Presentation of Chronic Hepatitis C • Often asymptomatic • Picked up by uncovering risk factors • Mild abnormalities of LFTs • If symptomatic suggests advanced fibrosis • Jaundice, ascites, hepatic encephalopathy

  5. Hepatitis C: A Global Health Problem 170 Million Carriers Worldwide, 3-4 M new cases/year EAST MEDITERRANEAN 20M WEST EUROPE 9 M FAR EAST ASIA 60 M U.S.A. 4 M SOUTH EAST ASIA 30 M AFRICA 32 M SOUTH AMERICA 10 M AUSTRALIA 0.2 M SOURCE, WHO 1999

  6. Risk Factors for Hepatitis C Occupational Accidental needle sticks Mucosal exposures Medical Blood transfusion (before 1992). Clotting factors before 1987 Organ transplantation (before 1992) Lifestyle • IVDA • Intranasal cocaine • Tattooing/piercings with contaminated needles/ink • High-risk sexual activity • Multiple partners • History of STDs

  7. Screening for Chronic Viral Hepatitis C Unexplained elevations of transaminases Patients with HIV Patients on hemodialysis Children born to HCV + mothers Sexual exposure, multiple partners Baby Boomers (1946-1964) History of incarceration CDC and Prevention.MMWR Recomm Rep. 1998;47(RR-19):1-39.

  8. Hepatitis C: A Global Health Problem 170 Million Carriers Worldwide, 3-4 M new cases/year EAST MEDITERRANEAN 20M WEST EUROPE 9 M FAR EAST ASIA 60 M U.S.A. 4 M SOUTH EAST ASIA 30 M AFRICA 32 M SOUTH AMERICA 10 M AUSTRALIA 0.2 M SOURCE, WHO 1999

  9. Hepatitis C Antibody (Anti-HCV) Test • Used for screening and diagnosis • Sensitivity over 99% (immunocompetent) • Detected 8-12 weeks after exposure Management of Hepatitis C. NIH Consensus Statement, 2002.

  10. Detection of Viral Hepatitis: HCV RNA Testing • RT-PCR (reverse transcription-polymerase chain reaction) • Quantitative (reported in IU/mL rather than copies/mL) • Specificity is 98-99% • Detected as early as 2 wks after exposure • Used if HCV antibody detected (or as clinically indicated) Pawlotski JM, Hepatology,November 2002

  11. Outcome Following HCV Infection 20-50 yrs 100 85% Chronic85 15% 20% Cirrhosis17 Resolve15 80% 25% 75% Mortality4 Stable68 Stable13 Courtesy of Seeff, LB and Alter, HJ.

  12. CDC Recommended Testing Sequence for Identifying Current HCV infection

  13. QUESTIONS?

More Related